EcoDrugPlus

Melanocortin 4 Receptor

Ensembl ID : ENSDLAG00005000468
Gene Symbol: MC4R
2 Cross references
211 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSDLAG00005024590
Gene Symbol: MTNR1AA
1 Cross references
190 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSDLAG00005007382
Gene Symbol: MME
1 Cross references
236 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSDLAG00005024721
Gene Symbol: METAP2
1 Cross references
229 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSDLAG00005013846
Gene Symbol: MAPK10
1 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSDLAG00005024940
Gene Symbol: MAPK3
1 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 8a

Ensembl ID : ENSDLAG00005001847
Gene Symbol: MAPK8A
1 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 8b

Ensembl ID : ENSDLAG00005015180
Gene Symbol: MAPK8B
1 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSDLAG00005005002
Gene Symbol: MAP2K1
1 Cross references
215 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 2a

Ensembl ID : ENSDLAG00005007532
Gene Symbol: MAP2K2A
1 Cross references
218 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 2b

Ensembl ID : ENSDLAG00005024852
Gene Symbol: MAP2K2B
1 Cross references
202 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 12

Ensembl ID : ENSDLAG00005011757
Gene Symbol: MAP3K12
1 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).